NCT03624283 is a NA clinical trial of Betahistine in Vestibular Disorder, sponsored by Eye & ENT Hospital of Fudan University.

Who is sponsoring NCT03624283?

NCT03624283 is sponsored by Eye & ENT Hospital of Fudan University.

What drugs are being tested in NCT03624283?

Interventions in NCT03624283: Betahistine, Exercise-based vestibular rehabilitation.

What condition does NCT03624283 study?

NCT03624283 studies Vestibular Disorder.

Is NCT03624283 still recruiting?

NCT03624283 is currently status unknown. Last updated 14 August 2018.

Last reviewed 2018-08-14 · How we verify

NCT03624283

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Interventions for Residual Dizziness After Successful Repositioning Maneuvers in Patients With BPPV

Status unknown NA Last updated 14 August 2018

What this trial tests

NA trial testing Betahistine in Vestibular Disorder in 183 participants. Status unknown.

Timeline

1 September 2018

Primary endpoint
31 December 2019

31 July 2020

Quick facts

Lead sponsor	Eye & ENT Hospital of Fudan University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	183
Start date	1 September 2018
Primary completion	31 December 2019
Estimated completion	31 July 2020
Sites	1 location across China

Drugs / interventions tested

Betahistine (BETAHISTINE) — full drug profile →
Exercise-based vestibular rehabilitation

Conditions studied

Vestibular Disorder — all drugs for Vestibular Disorder →

Sponsor

Eye & ENT Hospital of Fudan University

Who can join

Adults 18 to 80, any sex, with Vestibular Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate the effect of vestibular rehabilitation, with or without medication, on resolving residual dizziness after successful repositioning maneuvers in patients with benign paroxysmal positional.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effects of vestibular rehabilitation, with or without betahistine, on managing residual dizziness after successful repositioning manoeuvres in patients with benign paroxysmal positional vertigo: a protocol for a randomised controlled trial.
Wu P, Cao W, Hu Y, Li H. · · 2019 · cited 17× · PMID 31217316 · DOI 10.1136/bmjopen-2018-026711

Verify or expand the search:

Other recruiting trials for Vestibular Disorder

Currently open trials in the same condition.

NCT06688578 — Testing Effectiveness of a Stochastic Noise Stimulator to Immediately Improve Balance and Gait · NA · recruiting
NCT05942781 — Concurrent Vestibular Activation and Postural Training Using Virtual Reality · NA · active not recruiting
NCT03799991 — Vestibular Therapy in Alzheimer's Disease · NA · recruiting
NCT05622344 — StableEyes With Active Neurofeedback · NA · recruiting
NCT05414903 — Reading Outcomes in Children With Vestibular Loss · NA · recruiting

Other Eye & ENT Hospital of Fudan University trials

Trials by the same sponsor.

NCT07522879 — A Study of Becotatug Vedotin (MRG003) Combined With Epirubicin as Neoadjuvant Therapy for EGFR-Positive, Unresectable Re · Phase 2 · not yet recruiting
NCT07563088 — SPARE-1st: Surgery Alone vs Surgery Plus Postoperative Radiotherapy for Sinonasal Adenoid Cystic Carcinoma · not yet recruiting
NCT07575334 — Acupuncture Therapy for Sudden Sensorineural Hearing Loss · NA · recruiting
NCT07320508 — Epirubicin Interventional Chemotherapy for Sinonasal Adenoid Cystic Carcinoma (SNACC): A Prospective Study · Phase 2 · recruiting
NCT07315802 — New Pattern of Retinal Laser Treatment for PDR · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03624283 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Eye & ENT Hospital of Fudan University
Last refreshed: 14 August 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03624283.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing